...
首页> 外文期刊>Pharmacological research: The official journal of The Italian Pharmacological Society >Efficacy and safety of current therapeutic options for COVID-19-lessons to be learnt from SARS and MERS epidemic: A systematic review and meta-analysis
【24h】

Efficacy and safety of current therapeutic options for COVID-19-lessons to be learnt from SARS and MERS epidemic: A systematic review and meta-analysis

机译:来自SARS和MERS流行病的Covid-19课程当前治疗选择的疗效和安全性:系统审查和荟萃分析

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The rapidly progressing of coronavirus disease 2019 (COVID-19) pandemic has become a global concern. This meta-analysis aimed at evaluating the efficacy and safety of current option of therapies for severe acute respiratory syndrome (SARS), Middle Eastern respiratory syndrome (MERS) besides COVID-19, in an attempt to identify promising therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected patients.
机译:冠状病毒疾病2019(Covid-19)大流行的迅速进展已成为全球担忧。 此荟萃分析旨在评估目前对Covid-19的严重急性呼吸综合征(SARS),中东呼吸道综合征(MERS)疗法的疗效和安全性的疗效和安全性,试图确定对严重急性呼吸综合征冠状病毒的有前途治疗 2(SARS-COV-2)受感染的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号